+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Urinary Incontinence Treatment Devices Market Research Report by Incontinence, Product, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 140 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5532695
UP TO OFF until Dec 31st 2022
The United States Urinary Incontinence Treatment Devices Market size was estimated at USD 202.78 million in 2021, USD 215.62 million in 2022, and is projected to grow at a CAGR of 8.30% to reach USD 327.27 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Urinary Incontinence Treatment Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Incontinence, the market was studied across Mixed Incontinence, Overflow Incontinence, Stress Urinary Incontinence, and Urge Urinary Incontinence.
  • Based on Product, the market was studied across Artificial Urinary Sphincters, Catheters, Electrical Stimulation Devices, Urethral Slings, and Vaginal slings. The Electrical Stimulation Devices is further studied across Implantable and Non-Implantable. The Urethral Slings is further studied across Female Slings and Male Slings. The Vaginal slings is further studied across Advanced vaginal slings and Conventional vaginal slings.
  • Based on End User, the market was studied across Ambulatory Surgery Centers, Clinics, Home care settings, and Hospitals.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Urinary Incontinence Treatment Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Urinary Incontinence Treatment Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Urinary Incontinence Treatment Devices Market, including A.M.I. GmbH, Atlantic Therapeutics Group Ltd, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc, Coloplast A/S, ConvaTec Group PLC, Cook Medical Inc, Fresenius Medical Care AG & Co. KGaA, Hollister Incorporated, IMPLANTICA AG, Incontrol Medical LLC, Johnson & Johnson, Karl Storz GmbH & Co. KG, Medtronic PLC, Promedon Group, and ZSI Surgical Implants S.R.L..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Urinary Incontinence Treatment Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Urinary Incontinence Treatment Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Urinary Incontinence Treatment Devices Market?
4. What is the competitive strategic window for opportunities in the United States Urinary Incontinence Treatment Devices Market?
5. What are the technology trends and regulatory frameworks in the United States Urinary Incontinence Treatment Devices Market?
6. What is the market share of the leading vendors in the United States Urinary Incontinence Treatment Devices Market?
7. What modes and strategic moves are considered suitable for entering the United States Urinary Incontinence Treatment Devices Market?
Frequently Asked Questions about the U.S. Urinary Incontinence Treatment Devices Market

What is the estimated value of the U.S. Urinary Incontinence Treatment Devices Market?

The U.S. Urinary Incontinence Treatment Devices Market was estimated to be valued at $202.78 Million in 2021.

What is the growth rate of the U.S. Urinary Incontinence Treatment Devices Market?

The growth rate of the U.S. Urinary Incontinence Treatment Devices Market is 8.3%, with an estimated value of $327.27 Million by 2027.

What is the forecasted size of the U.S. Urinary Incontinence Treatment Devices Market?

The U.S. Urinary Incontinence Treatment Devices Market is estimated to be worth $327.27 Million by 2027.

Who are the key companies in the U.S. Urinary Incontinence Treatment Devices Market?

Key companies in the U.S. Urinary Incontinence Treatment Devices Market include A.M.I. GmbH, Atlantic Therapeutics Group Ltd, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc, Coloplast A/S, ConvaTec Group PLC and Fresenius Medical Care AG & Co. KGaA.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Urinary Incontinence Treatment Devices Market, by Incontinence
6.1. Introduction
6.2. Mixed Incontinence
6.3. Overflow Incontinence
6.4. Stress Urinary Incontinence
6.5. Urge Urinary Incontinence
7. Urinary Incontinence Treatment Devices Market, by Product
7.1. Introduction
7.2. Artificial Urinary Sphincters
7.3. Catheters
7.4. Electrical Stimulation Devices
7.5.1. Implantable
7.5.2. Non-Implantable
7.5. Urethral Slings
7.6.1. Female Slings
7.6.2. Male Slings
7.6. Vaginal slings
7.7.1. Advanced vaginal slings
7.7.2. Conventional vaginal slings
8. Urinary Incontinence Treatment Devices Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Clinics
8.4. Home care settings
8.5. Hospitals
9. California Urinary Incontinence Treatment Devices Market
9.1. Introduction
10. Florida Urinary Incontinence Treatment Devices Market
10.1. Introduction
11. Illinois Urinary Incontinence Treatment Devices Market
11.1. Introduction
12. New York Urinary Incontinence Treatment Devices Market
12.1. Introduction
13. Ohio Urinary Incontinence Treatment Devices Market
13.1. Introduction
14. Pennsylvania Urinary Incontinence Treatment Devices Market
14.1. Introduction
15. Texas Urinary Incontinence Treatment Devices Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. A.M.I. GmbH
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Atlantic Therapeutics Group Ltd
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. B. Braun Melsungen AG
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Becton, Dickinson and Company
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Boston Scientific Corporation
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Caldera Medical Inc
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Coloplast A/S
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. ConvaTec Group PLC
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. Cook Medical Inc
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Fresenius Medical Care AG & Co. KGaA
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Hollister Incorporated
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. IMPLANTICA AG
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Incontrol Medical LLC
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Johnson & Johnson
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Karl Storz GmbH & Co. KG
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Medtronic PLC
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Promedon Group
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
17.18. ZSI Surgical Implants S.R.L.
17.18.1. Business Overview
17.18.2. Key Executives
17.18.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET DYNAMICS
FIGURE 8. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY INCONTINENCE, 2027
FIGURE 11. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY MIXED INCONTINENCE, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY OVERFLOW INCONTINENCE, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY STRESS URINARY INCONTINENCE, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY URGE URINARY INCONTINENCE, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 18. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY NON-IMPLANTABLE, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY URETHRAL SLINGS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY FEMALE SLINGS, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY MALE SLINGS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY VAGINAL SLINGS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ADVANCED VAGINAL SLINGS, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CONVENTIONAL VAGINAL SLINGS, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 30. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 32. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 36. CALIFORNIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. FLORIDA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. ILLINOIS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. NEW YORK URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. OHIO URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. PENNSYLVANIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. TEXAS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 44. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 45. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY MIXED INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY MIXED INCONTINENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY OVERFLOW INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY OVERFLOW INCONTINENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY STRESS URINARY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY URGE URINARY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY URGE URINARY INCONTINENCE, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY IMPLANTABLE, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY NON-IMPLANTABLE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY NON-IMPLANTABLE, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY URETHRAL SLINGS, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY URETHRAL SLINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY FEMALE SLINGS, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY FEMALE SLINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY MALE SLINGS, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY MALE SLINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY VAGINAL SLINGS, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY VAGINAL SLINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ADVANCED VAGINAL SLINGS, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY ADVANCED VAGINAL SLINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CONVENTIONAL VAGINAL SLINGS, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CONVENTIONAL VAGINAL SLINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 44. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 45. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 46. CALIFORNIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. CALIFORNIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 48. CALIFORNIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 49. CALIFORNIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 50. FLORIDA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. FLORIDA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 52. FLORIDA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 53. FLORIDA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 54. ILLINOIS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. ILLINOIS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 56. ILLINOIS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 57. ILLINOIS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 58. NEW YORK URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 59. NEW YORK URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 60. NEW YORK URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 61. NEW YORK URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 62. OHIO URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. OHIO URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 64. OHIO URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 65. OHIO URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 66. PENNSYLVANIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 67. PENNSYLVANIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 68. PENNSYLVANIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 69. PENNSYLVANIA URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 70. TEXAS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 71. TEXAS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY INCONTINENCE, 2018-2027 (USD MILLION)
TABLE 72. TEXAS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 73. TEXAS URINARY INCONTINENCE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 74. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 75. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 76. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 77. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET RANKING, BY KEY PLAYER, 2021
TABLE 78. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 79. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET MERGER & ACQUISITION
TABLE 80. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 81. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 82. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET INVESTMENT & FUNDING
TABLE 83. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 84. UNITED STATES URINARY INCONTINENCE TREATMENT DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • A.M.I. GmbH
  • Atlantic Therapeutics Group Ltd
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Caldera Medical Inc
  • Coloplast A/S
  • ConvaTec Group PLC
  • Cook Medical Inc
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • IMPLANTICA AG
  • Incontrol Medical LLC
  • Johnson & Johnson
  • Karl Storz GmbH & Co. KG
  • Medtronic PLC
  • Promedon Group
  • ZSI Surgical Implants S.R.L.

Methodology

Loading
LOADING...